Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies
Authors
Keywords
Economic Evaluation, Time Cost, Metastatic Colorectal Cancer, Informal Care, Informal Caregiving
Journal
PHARMACOECONOMICS
Volume 33, Issue 2, Pages 123-135
Publisher
Springer Nature
Online
2014-10-14
DOI
10.1007/s40273-014-0218-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- REMCARE: reminiscence groups for people with dementia and their family caregivers – effectiveness and cost-effectiveness pragmatic multicentre randomised trial
- (2014) RT Woods et al. HEALTH TECHNOLOGY ASSESSMENT
- The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.
- (2014) M Bond et al. HEALTH TECHNOLOGY ASSESSMENT
- Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
- (2014) S Banerjee et al. HEALTH TECHNOLOGY ASSESSMENT
- Managing Cancer Pain at the End of Life with Multiple Strong Opioids: A Population-Based Retrospective Cohort Study in Primary Care
- (2014) Wei Gao et al. PLoS One
- How to Include Informal Care in Economic Evaluations
- (2013) Renske J. Hoefman et al. PHARMACOECONOMICS
- Cost-Effectiveness of One Year Dementia Follow-Up Care by Memory Clinics or General Practitioners: Economic Evaluation of a Randomised Controlled Trial
- (2013) Els Meeuwsen et al. PLoS One
- Is the societal approach wide enough to include relatives?
- (2013) Thomas Davidson et al. Applied Health Economics and Health Policy
- Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation
- (2012) Susanne Hartz et al. BMC Neurology
- Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial
- (2012) Renee Romeo et al. BRITISH JOURNAL OF PSYCHIATRY
- Cost-Effectiveness of Magnetic Resonance Imaging with a New Contrast Agent for the Early Diagnosis of Alzheimer's Disease
- (2012) Maria Biasutti et al. PLoS One
- The Inclusion of Informal Care in Applied Economic Evaluation: A Review
- (2012) Kacey Goodrich et al. VALUE IN HEALTH
- An economic evaluation of early assessment for Alzheimer’s disease in the United Kingdom
- (2011) Dennis Getsios et al. Alzheimers & Dementia
- Cost-effectiveness of memantine in moderate and severe Alzheimer's disease in Norway
- (2011) B. Rive et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment
- (2011) Gisela Kobelt et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Management of Patients with Malignant Bowel Obstruction and Stage IV Colorectal Cancer
- (2011) Kimberly Moore Dalal et al. JOURNAL OF PALLIATIVE MEDICINE
- QALYs and Carers
- (2011) Hareth Al-Janabi et al. PHARMACOECONOMICS
- Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models
- (2010) Balázs Nagy et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden
- (2010) Ingrid Lekander et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Caring for and caring about: Disentangling the caregiver effect and the family effect
- (2010) Ana Bobinac et al. JOURNAL OF HEALTH ECONOMICS
- Health Effects in Significant Others
- (2010) Ana Bobinac et al. MEDICAL DECISION MAKING
- Objective burden, resources, and other stressors among informal cancer caregivers: a hidden quality issue?
- (2010) Michelle van Ryn et al. PSYCHO-ONCOLOGY
- Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs
- (2010) Wendy J. Ungar et al. ARTHRITIS CARE & RESEARCH
- Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis
- (2009) Wilbert B. Van den Hout et al. ARTHRITIS AND RHEUMATISM
- Societal cost of rheumatoid arthritis patients in the US
- (2009) Howard Birnbaum et al. CURRENT MEDICAL RESEARCH AND OPINION
- Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinsonʼs Disease in the UK Setting
- (2009) Alan Haycox et al. DRUGS & AGING
- Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
- (2009) Peter Lindgren et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Modeling the Cost-Effectiveness of Galantamine for Mild to Moderately Severe Alzheimer's Disease in Korea
- (2009) Guk-Hee Suh VALUE IN HEALTH
- An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare
- (2008) Marc A Koopmanschap et al. PHARMACOECONOMICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started